Volv Global

Downloadable PDF for offline reading

From Mendel to AI phenotyping and the next big breakthroughs.

What’s Inside?

More than 350 million people live with rare disorders, that is, a condition with which fewer than 200,000 have been diagnosed. About 80 percent of these rare disorders are genetic in origin, and 95 percent have no treatment approved by the FDA.

The article covers:

  • From the Human Genome Project (HGP) to innovation in rare diseases
  • How the clues are locked-up in the EMR

  • AI can help HCPs unlock those clues

Send me the Volv PDF!